Cite
HARVARD Citation
Ohka, F. et al. (n.d.). ML-11 Tirabrutinib treatment for recurrent or refractory PCNSL. Neuro-oncology advances. pp. vi23-vi24. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ohka, F. et al. (n.d.). ML-11 Tirabrutinib treatment for recurrent or refractory PCNSL. Neuro-oncology advances. pp. vi23-vi24. [Online].